| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/28/2006 | WO2006099681A1 Isoflavonoid dimers |
| 09/28/2006 | WO2006067867A8 Cell adhesion factor expression inhibitor |
| 09/28/2006 | WO2006067330B1 Pharmaceutical compositions based on fluorinated sulphamides and sulphinimides |
| 09/28/2006 | WO2006051314A8 Guanidine derivatives as inhibitors of ddah |
| 09/28/2006 | WO2005080384A3 Benzimidazole derivative and use as aii receptor antagonist |
| 09/28/2006 | US20060217557 Polymorphic form XVI of fexofenadine hydrochloride |
| 09/28/2006 | US20060217530 Active against C5a receptors on polymorphonuclear leukocytes and macrophages; peptidomimetics; for treatment of inflammation |
| 09/28/2006 | US20060217429 Treating stroke or reccurence with an ACE inhibitor selected from quinapril, captropril, lisinopril, perindopril, trandolapril, enalapril, moexipril, fosinopril, ramipril, cilazapril, imidapril, spirapril, temocapril, benazepril, alacepril, ceronapril, delapril, moveltipril and trandolapril |
| 09/28/2006 | US20060217421 Fortifier |
| 09/28/2006 | US20060217407 Compositions and Formulations of 9-Nitrocamptothecin Polymorphs and Methods of Use Therefor |
| 09/28/2006 | US20060217403 Substituted 2-aminoacetamides and the use thereof |
| 09/28/2006 | US20060217397 Sustained release ranolazine formulations |
| 09/28/2006 | US20060217388 Phthalazine derivatives for treating inflammatory diseases |
| 09/28/2006 | US20060217373 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
| 09/28/2006 | US20060217364 Beta-lactamyl vasopressin V1a antagonists |
| 09/28/2006 | US20060217351 Method for treating cardiovascular diseases |
| 09/28/2006 | US20060217348 Pyrazolo[1,5-a] pyridines and medicines containing the same |
| 09/28/2006 | US20060217314 Feline hepatocyte growth factor |
| 09/28/2006 | US20060216755 IL1RL-1 as a cardiovascular disease marker and therapeutic target |
| 09/28/2006 | US20060216745 Polynucleotides, expression vectors, and host cells for culturing truncated tryptophanyl-tRNA synthetase polypeptides having chemokine activity; bioassay; drug screening; antitumor agents, antimetastasis agents |
| 09/28/2006 | US20060216739 Insulin-like growth factor binding protein |
| 09/28/2006 | US20060216317 Delivery of polynucleotide agents to the central nervous system |
| 09/28/2006 | US20060216301 Kdr peptides and vaccines containing the same |
| 09/28/2006 | US20060216268 Denaturants for sympathomimetic amine salts |
| 09/28/2006 | DE19724791B4 Thrombin hemmende Peptide, deren Verwendung und diese enthaltende pharmazeutische Zusammensetzungen Thrombin-inhibiting peptides, their use and pharmaceutical compositions containing them |
| 09/28/2006 | DE102005027150A1 Pyrimidincarbonsäure-Derivate und ihre Verwendung Pyrimidinecarboxylic acid derivatives and their use |
| 09/28/2006 | DE102005012873A1 Aminocarbonyl substituierte 8-N-Benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Aminocarbonyl substituted 8-N-benzimidazoles, process for their preparation and their use as medicaments |
| 09/28/2006 | CA2602946A1 Delivery systems and methods for diagnosing and treating cardiovascular diseases |
| 09/28/2006 | CA2602541A1 Isoflavonoid dimers |
| 09/28/2006 | CA2602520A1 Use of the mst protein for the treatment of a thromboembolic disorder |
| 09/28/2006 | CA2602514A1 Use of substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines for the treatment of reperfusion injury and reperfusion damage |
| 09/28/2006 | CA2602229A1 Substituted, bicyclic 8-pyrrolidino-benzimidazoles, method for their production and their use as medicaments |
| 09/28/2006 | CA2601766A1 N- [3- (1-amin0-5, 6, 7, 8-tetrahydro-2 , 4, 4b-triazafluoren-9-yl)-phenyl] benzamides as tyrosine/threonine kinase inhibitors, in particular b-raf kinase |
| 09/28/2006 | CA2601669A1 Methods of decreasing calcification |
| 09/28/2006 | CA2601401A1 Novel polymorph form g of fluvastatin sodium and process for the preparation thereof |
| 09/28/2006 | CA2601363A1 Nanoparticulate biphosphonate compositions |
| 09/28/2006 | CA2600074A1 Novel cyclic aminophenylalkanoic acid derivative |
| 09/28/2006 | CA2599794A1 Cinnamoyl compound and use thereof |
| 09/27/2006 | EP1705248A1 Fusion proteins comprising an angiostatin moiety and their use in anti-tumour treatment |
| 09/27/2006 | EP1705189A1 Feline hepatocyte growth factor |
| 09/27/2006 | EP1705184A1 Treatment of neoplastic diseases using a combination of plasminogen activators and sulfhydryl donors |
| 09/27/2006 | EP1705179A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 09/27/2006 | EP1705169A2 Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 09/27/2006 | EP1704857A1 Abca1 stabilizer |
| 09/27/2006 | EP1703918A2 Combination of crf antagonists and 5-ht 1b receptor antagonists |
| 09/27/2006 | EP1703911A1 Combination therapies employing a composition comprising a hmg coa reductase inhibitor and a vitamin b6 related compound |
| 09/27/2006 | EP1617834B1 Use of a pharmaceutical composition containing lactic acid or lactate and potassium for treating brain edema or brain injury |
| 09/27/2006 | EP1569666B1 Herbal preparation for management of cardiovascular and neurologic disorders |
| 09/27/2006 | EP1549334B1 Pharmaceutical composition comprising a retro-inverso isomer peptide |
| 09/27/2006 | EP1534687B1 2-phenylamino-4-trifluoromethyl-5-(benzyl- or pyridin-4-ylmethyl)carbamoylpyrimidine derivatives as selective cb2 cannabinoid receptor modulators |
| 09/27/2006 | EP1461062B1 Composition and method for treating chronic allograft rejection |
| 09/27/2006 | EP1450792B1 Benzazole derivatives for the treatment of scleroderma |
| 09/27/2006 | EP1383757B1 Antagonists of mcp-1 function and methods of use thereof |
| 09/27/2006 | EP1377580B1 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor |
| 09/27/2006 | EP1337521B1 Salts of an isothiazole-4-carboxamide and their use as anti-hyperproliferation agents |
| 09/27/2006 | EP1196433B1 CYCLIC PEPTIDE DERIVATIVES AS INHIBITORS OF INTEGRIN ALPHA v BETA 6 |
| 09/27/2006 | EP1000079B1 New formulation |
| 09/27/2006 | EP0983765B1 Preventives or remedies for diseases in association with vascular functional anomaly relating to insulin resistance |
| 09/27/2006 | CN1838957A Chemokine inhibiting piperazine derivatives and their use to treat myocarditis |
| 09/27/2006 | CN1838952A Use of [3.2.0] heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases |
| 09/27/2006 | CN1838949A Pharmaceutical composition comprising a combination of metformin and a statin |
| 09/27/2006 | CN1837241A Interactive molecular binding domain of angiogenin and LIM protein |
| 09/27/2006 | CN1837240A Interactive molecular binding domain of angiogenin and lambda crystallin |
| 09/27/2006 | CN1837236A Polypeptide of extracellular domain of sodium pump and use in preparation of drugs for adjusting the activity of sodium pump |
| 09/27/2006 | CN1837213A Bilobalide A derivatives and pharmaceutical application thereof |
| 09/27/2006 | CN1837212A Bilobalide B derivatives and pharmaceutical application thereof |
| 09/27/2006 | CN1837207A Pirazino(aza)indole derivatives |
| 09/27/2006 | CN1837202A Flavonols with blood-fat-lowering effect |
| 09/27/2006 | CN1837199A Tanshinone I derivatives and pharmaceutical application thereof |
| 09/27/2006 | CN1836717A Quality controlling method for pulse restoring injection |
| 09/27/2006 | CN1836709A Daphne freeze-drying powder injection and its preparation method |
| 09/27/2006 | CN1836698A Medicine composition for treating hyperlipemia and coronary disease and preparation method thereof |
| 09/27/2006 | CN1836694A Medicine composition for treating cardiovascular diseases and preparation method thereof |
| 09/27/2006 | CN1836681A Ginseng stem leaves general saponin freeze-drying powder injection and its preparation method |
| 09/27/2006 | CN1836680A Compound notoginsen triterpenes puerarin preparation |
| 09/27/2006 | CN1836664A Puerarin self-emulsifying microemulsified composition and its preparation method |
| 09/27/2006 | CN1836657A Polymethoxylated flavones and its preparation method |
| 09/27/2006 | CN1836655A Electrolyte replenisher for treating hypopotassaemia hypomagnesemia and its uses |
| 09/27/2006 | CN1836650A Antineoplastic precharging preparation |
| 09/27/2006 | CN1836534A Geranium tea and preparation method thereof |
| 09/27/2006 | CN1276928C Cell apoptosis regulating protein related with heart failure |
| 09/27/2006 | CN1276920C Thiazolidinedione derivatives and pharmaceutical composition comprising the same |
| 09/27/2006 | CN1276759C Injection liquid for treating heart brain blood vessel disease and its preparation method |
| 09/27/2006 | CN1276755C Chinese medicinal effective part composition for treating cerebrovascular and cardiovascular disease |
| 09/27/2006 | CN1276752C Bilobalide soft capsule and its preparation method |
| 09/26/2006 | US7112685 Labeled resiniferatoxin derivatives |
| 09/26/2006 | US7112667 Sequences of an Ih ion channel and use thereof |
| 09/26/2006 | US7112666 Von Willebrand Factor (Vwf)-cleaving protease |
| 09/26/2006 | US7112654 Ligand for vascular endothelial growth factor receptor |
| 09/26/2006 | US7112611 Antitumor, anticancer agents; respiratory system disorders; brain disorders |
| 09/26/2006 | US7112607 Antihypoxic agents, antiischamic agents, antiarrhythmia agents |
| 09/26/2006 | US7112606 Heterocyclic arylsulfonamidobenzylic compounds |
| 09/26/2006 | US7112603 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 09/26/2006 | US7112597 5-(Substituted thiazolylethoxy)indaneacetic acid derivatives, used in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases |
| 09/26/2006 | US7112593 N-aryl-substituted cyclic amine derivative and medicine containing the same as active ingredient |
| 09/26/2006 | US7112592 Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents |
| 09/26/2006 | US7112589 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases |
| 09/26/2006 | US7112580 3-nitrogen-6, 7-dioxygen steroids and uses related thereto |
| 09/26/2006 | US7112574 found to be potent adenosine receptor agonists, in particular for the A2A receptor. |
| 09/26/2006 | US7112571 Peptide Y-2 |